TU PHAN: Open Payments
NPI 1689078156 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 31 payments from 10 companies in 2025. Trend: 2023 $1,049 · 2024 $795 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $147 |
| PFIZER INC. | 6 | $106 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Amgen Inc. | 3 | $45 |
| Novo Nordisk Inc | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Exact Sciences Corporation | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: QULIPTA, UBRELVY, CAPLYTA, NURTEC ODT, PREVNAR 20, GEMTESA, AIRSUPRA, BREZTRI.
Industry payments across AR — which companies pay providers there.
